JAAD Case Reports (Feb 2021)

Infusion reaction to infliximab biosimilar after transitioning from infliximab

  • Reem Kashlan, MPH,
  • Alexis B. Lyons, MD,
  • Shanthi Narla, MD,
  • Iltefat H. Hamzavi, MD

Journal volume & issue
Vol. 8
pp. 77 – 79

Abstract

Read online

No abstracts available.

Keywords